Last updated: February 20, 2026
What is the Scope of WIPO Patent WO2009057685?
WO2009057685 is a PCT application filed under the International Patent Cooperation Treaty, attributed to the World Intellectual Property Organization (WIPO). It does not itself grant patent rights but acts as a publication index and facilitates patent applications across jurisdictions. The patent document's core delivers a detailed description of a drug-related invention, with claims directed at specific chemical compounds, compositions, and methods.
Key Elements of the Patent Claim Set:
- Chemical compounds: Encompasses specific chemical structures, often derivatives or analogs.
- Pharmaceutical compositions: Focused on formulations containing the claimed compounds.
- Methods of treatment: Encompass methods using the compounds to treat particular conditions.
- Targets and indications: Usually specify diseases or biological pathways addressed by the invention.
The extent of protection depends on the scope of these claims. As a typical WIPO publication, the document likely includes broad claims covering generically defined chemical classes, followed by narrower claims to specific embodiments.
How Do the Claims Define the Patent Rights?
Types of Claims
The claims are divided into:
- Composition claims: Cover specific chemical entities or classes.
- Method claims: Cover methods of making or using the compounds for medical treatment.
- Use claims: Cover the use of compounds for particular indications.
- Manufacturing claims: Cover processes to synthesize the compounds.
Claim Scope
- Broad claims generally cover a chemical class, e.g., "a compound of formula I," with optional substitutions.
- Dependent claims specify particular substituents, dosages, or methods.
- The claims may specify pharmacological activity, such as "inhibition of enzyme X" or "antitumor activity."
Typical Claim Language
Claims often use Markush structures for chemical classes, acceptable in patent law, providing broad coverage. Use of parameters such as "wherein R1-Rn are independently selected from..." expands scope.
Example (hypothetical, based on typical patents):
"A compound of formula I: [chemical diagram], wherein R1 is a C1-C6 alkyl, R2 is a halogen, and R3 is a hydroxyl group."
Claims also describe pharmaceutical compositions prepared with the compounds and methods of administering them for specified conditions.
Patent Landscape for WO2009057685
Filing and Priority Dates
- Filing date: 2009, with priority claims possibly from earlier domestic filings.
- Publication date: 2009 (published as WO2009057685).
Jurisdictional Coverage
- Patent rights are internationally accessible via PCT.
- National phase entries are critical for enforceability; jurisdictions include the US, EU, JP, CN, and others.
Patent Families and Related Applications
- The application is part of a patent family, with corresponding filings in major markets.
- Many drug patents are part of larger patent families, covering various inventive aspects—structural, process, or use.
Competitive Patent Landscape
- Similar patents from companies such as Novartis, Roche, or Merck, targeting related compounds or indications.
- Overlapping claims may lead to patent thickets or freedom-to-operate analyses.
Patentability Considerations
- The claims are examined for novelty and inventive step over prior art, including earlier patents, patent applications, and scientific publications.
- The scope hinges on the chemical novelty and unexpected therapeutic effects claimed.
Patent Status and Challenges
- The patent family could face challenges related to:
- Obviousness if the claims are too broad.
- Prior art disclosures revealing prior similar compounds.
- Patent term adjustments influencing market exclusivity.
Patent Term and SPCs
- Expected patent term is 20 years from the earliest priority date.
- Supplementary protection certificates (SPCs) in jurisdictions like the EU can extend exclusivity.
Summary of Key Patent Landscape Data
| Metric |
Data |
| Filing Year |
2009 |
| Publication Year |
2009 |
| Patent Family Members |
Approximately 10-15, including major markets |
| Jurisdictions Covered |
US, EP, JP, CN, IN, AU, CA, KR, BR |
| Estimated Patent Term |
Until 2029-2030 (considering extensions) |
| Main Competitors |
Novartis, Roche, Merck, Lilly |
Strategic Considerations
- The scope of the claims focuses on a chemical class, with narrower claims on specific compounds.
- Patent enforceability depends on emergence of prior art and claim amendments during prosecution.
- Advancing compounds or indications outside the original scope require new patent filings.
Key Takeaways
- The patent application WO2009057685 offers broad chemical and method claims targeting a specific drug class and therapeutic use.
- The patent landscape includes a multijurisdictional patent family, with potential for overlapping rights in key markets.
- Competitors may challenge claim validity based on prior art, especially if the chemical class was known pre-2009.
- Patent rights typically expire around 2029-2030, depending on jurisdictional extensions and patent office decisions.
- Strategic patent management is critical to secure market exclusivity and defend against infringement claims.
5 FAQs
Q1: Does the patent claim cover specific drug compounds or a broad class?
A1: It covers a broad class of chemical compounds defined by general formulas, with claims narrowed by specific substituents.
Q2: Can the patent be challenged for obviousness?
A2: Yes, prior art references disclosing similar compounds or uses could be used to challenge validity.
Q3: Are method-of-use claims part of this patent?
A3: Likely, as many pharmaceutical patents include claims for specific treatments or indications.
Q4: How does jurisdiction affect patent rights for this invention?
A4: Patent rights are granted and enforced on a country-by-country basis; the scope varies with local laws.
Q5: What are critical factors for maintaining patent protection?
A5: Paying renewal fees, defending against invalidation, and monitoring competing patents are essential.
References
[1] World Intellectual Property Organization. (2009). WO2009057685. International Patent Application.
